Home LiteratureArticle Details
PMID: 10473672 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Atrial L-type Ca2+ currents and human atrial fibrillation.

Circulation research ·Vol. 85 ·No. 5 ·1999-09-03 ·Pages 428-36

Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM

Abstract

Chronic atrial fibrillation (AF) is characterized by decreased atrial contractility, shortened action potential duration, and decreased accommodation of action potential duration to changes in activation rate. Studies on experimental animal models of AF implicate a reduction in L-type Ca2+ current (I(Ca)) density in these changes. To evaluate the effect of AF on human I(Ca), we compared I(Ca) in atrial myocytes isolated from 42 patients in normal sinus rhythm at the time of cardiac surgery with that of 11 chronic AF patients. I(Ca) was significantly reduced in the myocytes of patients with chronic AF (mean -3.35+/-0.5 pA/pF versus -9.13+/-1. 0 pA/pF in the controls), with no difference between groups in the voltage dependence of activation or steady-state inactivation. Although I(Ca) was lower in myocytes from the chronic AF patients, their response to maximal beta-adrenergic stimulation was not impaired. Postoperative AF frequently follows cardiac surgery. Half of the patients in the control group (19/38) of this study experienced postoperative AF. Whereas chronic AF is characterized by reduced atrial I(Ca), the patients with the greatest I(Ca) had an increased incidence of postoperative AF, independent of patient age or diagnosis. This observation is consistent with the concept that calcium overload may be an important factor in the initiation of AF. The reduction in functional I(Ca) density in myocytes from the atria of chronic AF patients may thus be an adaptive response to the arrhythmia-induced calcium overload.

MeSH Terms
Action Potentials/drug effects Adrenergic beta-Agonists/pharmacology Adult Aged Aged, 80 and over Atrial Fibrillation/drug therapy,etiology,physiopathology,surgery Calcium/metabolism Calcium Channel Blockers/pharmacology Calcium Channels/biosynthesis,drug effects,genetics,physiology Calcium Channels, L-Type Calcium Signaling/drug effects Cells, Cultured Chronic Disease Coronary Artery Bypass Disease Susceptibility Female Gene Expression Regulation Heart Atria/pathology,physiopathology Heart Conduction System/physiopathology Heart Transplantation Heart Valve Prosthesis Implantation Humans Ion Channel Gating/drug effects Ion Transport/drug effects Isoproterenol/pharmacology Male Middle Aged Muscle Proteins/biosynthesis,genetics Myocardial Contraction/drug effects Nifedipine/pharmacology Patch-Clamp Techniques Postoperative Complications/physiopathology
Chemicals
Adrenergic beta-Agonists Calcium Channel Blockers Calcium Channels Calcium Channels, L-Type Muscle Proteins Nifedipine Isoproterenol Calcium
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Van Wagoner D R
Department of Cardiology and Kaufman Center for Heart Failure, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. [email protected]
Pond A L
Lamorgese M
Rossie S S
McCarthy P M
Nerbonne J M
Article Info
Journal
Circulation research
Abbr.
Circ Res
ISSN
0009-7330
Published
1999-09-03
Pages
428-36
Language
English
Region
United States
NLM ID
0047103
Subset
IM
Grants
NHLBI NIH HHS · F32-HL09987 · United States
NHLBI NIH HHS · R01-HL57262 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]